Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis

To investigate the rate of radiographic progression, as measured with the carpo-metacarpal ratio (Poznanski score), during etanercept (ETN) therapy in children with polyarticular juvenile idiopathic arthritis (JIA). Patients included in the Italian ETN registry who had a standard radiograph of both...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental rheumatology 2008-07, Vol.26 (4), p.688-692
Hauptverfasser: NIELSEN, S, RUPERTO, N, BARCELLONA, R, GALLIZZI, R, ROSSI, F, MAGNI-MANZONI, S, LOMBARDINI, G, FILOCAMO, G, RASCHETTI, R, MARTINI, A, RAVELLI, A, GERLONI, V, SIMONINI, G, CORTIS, E, LEPORE, L, ALPIGIANI, M. G, ZULIAN, F, CORONA, F, ALESSIO, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 692
container_issue 4
container_start_page 688
container_title Clinical and experimental rheumatology
container_volume 26
creator NIELSEN, S
RUPERTO, N
BARCELLONA, R
GALLIZZI, R
ROSSI, F
MAGNI-MANZONI, S
LOMBARDINI, G
FILOCAMO, G
RASCHETTI, R
MARTINI, A
RAVELLI, A
GERLONI, V
SIMONINI, G
CORTIS, E
LEPORE, L
ALPIGIANI, M. G
ZULIAN, F
CORONA, F
ALESSIO, M
description To investigate the rate of radiographic progression, as measured with the carpo-metacarpal ratio (Poznanski score), during etanercept (ETN) therapy in children with polyarticular juvenile idiopathic arthritis (JIA). Patients included in the Italian ETN registry who had a standard radiograph of both hands and wrists in the posteroanterior view made at start of treatment and after 1 year were included in the study. The clinical response was assessed by means of the ACR Pediatric definition of improvement. Radiographic progression was determined by calculating the change in the Poznanski score between the baseline and the 1-year radiographs. A total of 40 patients were studied. The frequency of ACR pediatric 30, 50, and 70 response at 1 year was 77%, 72%, and 50%, respectively. The median change in the Poznanski score between baseline and 1 year was + 0.3 units, meaning that, on average, patients experienced improvement in radiographic progression. Our pilot study provides evidence that ETN is potentially capable of reducing the progression of radiographic joint damage in JIA. This finding deserves confirmation in a controlled trial.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69573366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69573366</sourcerecordid><originalsourceid>FETCH-LOGICAL-g265t-f0ac6ea05e4c5814e3c8e77e3a540983bcc13cc92f95cc8c72ede7892d3cddde3</originalsourceid><addsrcrecordid>eNo90E1LAzEQBuAgiq3VvyC56G0hu2m-jlL8goIeFHpb0slsm7K7XZNsof_eiNXTDMzDMPOekWkpDC-Y0atzMmXcVIUWcjUhVzHuGKukkOqSTEqtjCmZmhL_HrD1ne9tOFI8eIc9IE1bmygm22MAHBLt7JEGdGMeBev8fhPssPVAh5BbjNHve-p7uhsP2PsWqc9msOmH2JC2wScfr8lFY9uIN6c6I59Pjx-Ll2L59vy6eFgWm3xdKhpmQaJlAucgdDlHDhqVQm7FPL_F1wAlBzBVYwSABlWhQ6VN5Tg455DPyP3v3nzc14gx1Z2PgG2bv9mPsZZGKM6lzPD2BMd1h64egu9yCvVfOBncnYCNYNsm2B58_HcVk1qpSvFv2Ctyeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69573366</pqid></control><display><type>article</type><title>Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>NIELSEN, S ; RUPERTO, N ; BARCELLONA, R ; GALLIZZI, R ; ROSSI, F ; MAGNI-MANZONI, S ; LOMBARDINI, G ; FILOCAMO, G ; RASCHETTI, R ; MARTINI, A ; RAVELLI, A ; GERLONI, V ; SIMONINI, G ; CORTIS, E ; LEPORE, L ; ALPIGIANI, M. G ; ZULIAN, F ; CORONA, F ; ALESSIO, M</creator><creatorcontrib>NIELSEN, S ; RUPERTO, N ; BARCELLONA, R ; GALLIZZI, R ; ROSSI, F ; MAGNI-MANZONI, S ; LOMBARDINI, G ; FILOCAMO, G ; RASCHETTI, R ; MARTINI, A ; RAVELLI, A ; GERLONI, V ; SIMONINI, G ; CORTIS, E ; LEPORE, L ; ALPIGIANI, M. G ; ZULIAN, F ; CORONA, F ; ALESSIO, M ; Italian Pediatric Rheumatology Study Group</creatorcontrib><description>To investigate the rate of radiographic progression, as measured with the carpo-metacarpal ratio (Poznanski score), during etanercept (ETN) therapy in children with polyarticular juvenile idiopathic arthritis (JIA). Patients included in the Italian ETN registry who had a standard radiograph of both hands and wrists in the posteroanterior view made at start of treatment and after 1 year were included in the study. The clinical response was assessed by means of the ACR Pediatric definition of improvement. Radiographic progression was determined by calculating the change in the Poznanski score between the baseline and the 1-year radiographs. A total of 40 patients were studied. The frequency of ACR pediatric 30, 50, and 70 response at 1 year was 77%, 72%, and 50%, respectively. The median change in the Poznanski score between baseline and 1 year was + 0.3 units, meaning that, on average, patients experienced improvement in radiographic progression. Our pilot study provides evidence that ETN is potentially capable of reducing the progression of radiographic joint damage in JIA. This finding deserves confirmation in a controlled trial.</description><identifier>ISSN: 0392-856X</identifier><identifier>EISSN: 1593-098X</identifier><identifier>PMID: 18799107</identifier><language>eng</language><publisher>Pisa: Clinical and Experimental Rheumatology</publisher><subject>Arthritis, Juvenile - diagnostic imaging ; Arthritis, Juvenile - drug therapy ; Biological and medical sciences ; Child ; Child, Preschool ; Diseases of the osteoarticular system ; Etanercept ; Female ; Humans ; Immunoglobulin G - therapeutic use ; Immunomodulators ; Immunosuppressive Agents - therapeutic use ; Inflammatory joint diseases ; Male ; Medical sciences ; Metacarpal Bones - diagnostic imaging ; Pharmacology. Drug treatments ; Radiography ; Receptors, Tumor Necrosis Factor - therapeutic use ; Registries ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome</subject><ispartof>Clinical and experimental rheumatology, 2008-07, Vol.26 (4), p.688-692</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20687727$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18799107$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NIELSEN, S</creatorcontrib><creatorcontrib>RUPERTO, N</creatorcontrib><creatorcontrib>BARCELLONA, R</creatorcontrib><creatorcontrib>GALLIZZI, R</creatorcontrib><creatorcontrib>ROSSI, F</creatorcontrib><creatorcontrib>MAGNI-MANZONI, S</creatorcontrib><creatorcontrib>LOMBARDINI, G</creatorcontrib><creatorcontrib>FILOCAMO, G</creatorcontrib><creatorcontrib>RASCHETTI, R</creatorcontrib><creatorcontrib>MARTINI, A</creatorcontrib><creatorcontrib>RAVELLI, A</creatorcontrib><creatorcontrib>GERLONI, V</creatorcontrib><creatorcontrib>SIMONINI, G</creatorcontrib><creatorcontrib>CORTIS, E</creatorcontrib><creatorcontrib>LEPORE, L</creatorcontrib><creatorcontrib>ALPIGIANI, M. G</creatorcontrib><creatorcontrib>ZULIAN, F</creatorcontrib><creatorcontrib>CORONA, F</creatorcontrib><creatorcontrib>ALESSIO, M</creatorcontrib><creatorcontrib>Italian Pediatric Rheumatology Study Group</creatorcontrib><title>Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis</title><title>Clinical and experimental rheumatology</title><addtitle>Clin Exp Rheumatol</addtitle><description>To investigate the rate of radiographic progression, as measured with the carpo-metacarpal ratio (Poznanski score), during etanercept (ETN) therapy in children with polyarticular juvenile idiopathic arthritis (JIA). Patients included in the Italian ETN registry who had a standard radiograph of both hands and wrists in the posteroanterior view made at start of treatment and after 1 year were included in the study. The clinical response was assessed by means of the ACR Pediatric definition of improvement. Radiographic progression was determined by calculating the change in the Poznanski score between the baseline and the 1-year radiographs. A total of 40 patients were studied. The frequency of ACR pediatric 30, 50, and 70 response at 1 year was 77%, 72%, and 50%, respectively. The median change in the Poznanski score between baseline and 1 year was + 0.3 units, meaning that, on average, patients experienced improvement in radiographic progression. Our pilot study provides evidence that ETN is potentially capable of reducing the progression of radiographic joint damage in JIA. This finding deserves confirmation in a controlled trial.</description><subject>Arthritis, Juvenile - diagnostic imaging</subject><subject>Arthritis, Juvenile - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Diseases of the osteoarticular system</subject><subject>Etanercept</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin G - therapeutic use</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Inflammatory joint diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metacarpal Bones - diagnostic imaging</subject><subject>Pharmacology. Drug treatments</subject><subject>Radiography</subject><subject>Receptors, Tumor Necrosis Factor - therapeutic use</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Treatment Outcome</subject><issn>0392-856X</issn><issn>1593-098X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90E1LAzEQBuAgiq3VvyC56G0hu2m-jlL8goIeFHpb0slsm7K7XZNsof_eiNXTDMzDMPOekWkpDC-Y0atzMmXcVIUWcjUhVzHuGKukkOqSTEqtjCmZmhL_HrD1ne9tOFI8eIc9IE1bmygm22MAHBLt7JEGdGMeBev8fhPssPVAh5BbjNHve-p7uhsP2PsWqc9msOmH2JC2wScfr8lFY9uIN6c6I59Pjx-Ll2L59vy6eFgWm3xdKhpmQaJlAucgdDlHDhqVQm7FPL_F1wAlBzBVYwSABlWhQ6VN5Tg455DPyP3v3nzc14gx1Z2PgG2bv9mPsZZGKM6lzPD2BMd1h64egu9yCvVfOBncnYCNYNsm2B58_HcVk1qpSvFv2Ctyeg</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>NIELSEN, S</creator><creator>RUPERTO, N</creator><creator>BARCELLONA, R</creator><creator>GALLIZZI, R</creator><creator>ROSSI, F</creator><creator>MAGNI-MANZONI, S</creator><creator>LOMBARDINI, G</creator><creator>FILOCAMO, G</creator><creator>RASCHETTI, R</creator><creator>MARTINI, A</creator><creator>RAVELLI, A</creator><creator>GERLONI, V</creator><creator>SIMONINI, G</creator><creator>CORTIS, E</creator><creator>LEPORE, L</creator><creator>ALPIGIANI, M. G</creator><creator>ZULIAN, F</creator><creator>CORONA, F</creator><creator>ALESSIO, M</creator><general>Clinical and Experimental Rheumatology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20080701</creationdate><title>Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis</title><author>NIELSEN, S ; RUPERTO, N ; BARCELLONA, R ; GALLIZZI, R ; ROSSI, F ; MAGNI-MANZONI, S ; LOMBARDINI, G ; FILOCAMO, G ; RASCHETTI, R ; MARTINI, A ; RAVELLI, A ; GERLONI, V ; SIMONINI, G ; CORTIS, E ; LEPORE, L ; ALPIGIANI, M. G ; ZULIAN, F ; CORONA, F ; ALESSIO, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g265t-f0ac6ea05e4c5814e3c8e77e3a540983bcc13cc92f95cc8c72ede7892d3cddde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Arthritis, Juvenile - diagnostic imaging</topic><topic>Arthritis, Juvenile - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Diseases of the osteoarticular system</topic><topic>Etanercept</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin G - therapeutic use</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Inflammatory joint diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metacarpal Bones - diagnostic imaging</topic><topic>Pharmacology. Drug treatments</topic><topic>Radiography</topic><topic>Receptors, Tumor Necrosis Factor - therapeutic use</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NIELSEN, S</creatorcontrib><creatorcontrib>RUPERTO, N</creatorcontrib><creatorcontrib>BARCELLONA, R</creatorcontrib><creatorcontrib>GALLIZZI, R</creatorcontrib><creatorcontrib>ROSSI, F</creatorcontrib><creatorcontrib>MAGNI-MANZONI, S</creatorcontrib><creatorcontrib>LOMBARDINI, G</creatorcontrib><creatorcontrib>FILOCAMO, G</creatorcontrib><creatorcontrib>RASCHETTI, R</creatorcontrib><creatorcontrib>MARTINI, A</creatorcontrib><creatorcontrib>RAVELLI, A</creatorcontrib><creatorcontrib>GERLONI, V</creatorcontrib><creatorcontrib>SIMONINI, G</creatorcontrib><creatorcontrib>CORTIS, E</creatorcontrib><creatorcontrib>LEPORE, L</creatorcontrib><creatorcontrib>ALPIGIANI, M. G</creatorcontrib><creatorcontrib>ZULIAN, F</creatorcontrib><creatorcontrib>CORONA, F</creatorcontrib><creatorcontrib>ALESSIO, M</creatorcontrib><creatorcontrib>Italian Pediatric Rheumatology Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NIELSEN, S</au><au>RUPERTO, N</au><au>BARCELLONA, R</au><au>GALLIZZI, R</au><au>ROSSI, F</au><au>MAGNI-MANZONI, S</au><au>LOMBARDINI, G</au><au>FILOCAMO, G</au><au>RASCHETTI, R</au><au>MARTINI, A</au><au>RAVELLI, A</au><au>GERLONI, V</au><au>SIMONINI, G</au><au>CORTIS, E</au><au>LEPORE, L</au><au>ALPIGIANI, M. G</au><au>ZULIAN, F</au><au>CORONA, F</au><au>ALESSIO, M</au><aucorp>Italian Pediatric Rheumatology Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis</atitle><jtitle>Clinical and experimental rheumatology</jtitle><addtitle>Clin Exp Rheumatol</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>26</volume><issue>4</issue><spage>688</spage><epage>692</epage><pages>688-692</pages><issn>0392-856X</issn><eissn>1593-098X</eissn><abstract>To investigate the rate of radiographic progression, as measured with the carpo-metacarpal ratio (Poznanski score), during etanercept (ETN) therapy in children with polyarticular juvenile idiopathic arthritis (JIA). Patients included in the Italian ETN registry who had a standard radiograph of both hands and wrists in the posteroanterior view made at start of treatment and after 1 year were included in the study. The clinical response was assessed by means of the ACR Pediatric definition of improvement. Radiographic progression was determined by calculating the change in the Poznanski score between the baseline and the 1-year radiographs. A total of 40 patients were studied. The frequency of ACR pediatric 30, 50, and 70 response at 1 year was 77%, 72%, and 50%, respectively. The median change in the Poznanski score between baseline and 1 year was + 0.3 units, meaning that, on average, patients experienced improvement in radiographic progression. Our pilot study provides evidence that ETN is potentially capable of reducing the progression of radiographic joint damage in JIA. This finding deserves confirmation in a controlled trial.</abstract><cop>Pisa</cop><pub>Clinical and Experimental Rheumatology</pub><pmid>18799107</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0392-856X
ispartof Clinical and experimental rheumatology, 2008-07, Vol.26 (4), p.688-692
issn 0392-856X
1593-098X
language eng
recordid cdi_proquest_miscellaneous_69573366
source MEDLINE; Alma/SFX Local Collection
subjects Arthritis, Juvenile - diagnostic imaging
Arthritis, Juvenile - drug therapy
Biological and medical sciences
Child
Child, Preschool
Diseases of the osteoarticular system
Etanercept
Female
Humans
Immunoglobulin G - therapeutic use
Immunomodulators
Immunosuppressive Agents - therapeutic use
Inflammatory joint diseases
Male
Medical sciences
Metacarpal Bones - diagnostic imaging
Pharmacology. Drug treatments
Radiography
Receptors, Tumor Necrosis Factor - therapeutic use
Registries
Retrospective Studies
Severity of Illness Index
Treatment Outcome
title Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T21%3A40%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20evidence%20that%20etanercept%20may%20reduce%20radiographic%20progression%20in%20juvenile%20idiopathic%20arthritis&rft.jtitle=Clinical%20and%20experimental%20rheumatology&rft.au=NIELSEN,%20S&rft.aucorp=Italian%20Pediatric%20Rheumatology%20Study%20Group&rft.date=2008-07-01&rft.volume=26&rft.issue=4&rft.spage=688&rft.epage=692&rft.pages=688-692&rft.issn=0392-856X&rft.eissn=1593-098X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E69573366%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69573366&rft_id=info:pmid/18799107&rfr_iscdi=true